The novel treatment of this peptide represents a significant advance in the management of type 2 diabetes. Different to existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide363249.designi1.com/62792802/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment